Design and in vitro evaluation of an extended-release matrix tablet for once-daily oral administration of oxybutynin
- 1 January 2005
- journal article
- abstracts
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 15 (5) , 397-402
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Oxybutynin Extended-ReleaseDrugs, 2004
- Transdermal oxybutynin: a new treatment for overactive bladderExpert Opinion on Pharmacotherapy, 2003
- Design of a silicone reservoir intravaginal ring for the delivery of oxybutyninJournal of Controlled Release, 2003
- An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladderClinical Therapeutics, 1999
- In-vitro cytochrome P450 dependent metabolism of oxybutynin to N-deethyloxybutynin in humansPharmacogenetics, 1998
- Cytochrome P450 Specificity of Metabolism and Interactions of Oxybutynin in Human Liver MicrosomesBasic & Clinical Pharmacology & Toxicology, 1998
- Comparison of a 10-mg controlled release oxybutynin tablet with a 5-mg oxybutynin tablet in urge incontinent patientsNeurourology and Urodynamics, 1997
- OxybutyninDrugs & Aging, 1995
- Oxybutynin and Uniary IncontinenceAge and Ageing, 1990
- Topical Oxybutynin Chloride for Relaxation of Dysfunctional BladdersJournal of Urology, 1989